WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 1-December 2016 (data as of 18-November-2016)
Next overall update June 2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 4'2201 Infant (under 12 months) mortality rate: 22
GDP / capita (US$): 9'1841 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 6'639  6'553  6'466  6'379  6'294  5'303  4'214  3'181 
Births 141  140  140  139  139  143  141  117 
Surviving infants 137  136  136  135  135  138  135  111 
Pop. less than 5 years 674  675  679  684  683  705  654  508 
Pop. less than 15 years 2'001  2'003  2'011  2'020  2'028  2'027  1'738  1'352 
Female 15-49 years 1'734  1'706  1'676  1'645  1'615  1'286  980  720 

Number of reported cases

(Click for retrospective incidence data for Paraguay)
Diphtheria
ChartChart
  10  14 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  1'396  745 
Mumps
ChartChart
  178  147  172  247  283  527 
Pertussis
ChartChart
  32  101  81  44  11  24  115  652 
Polio*
ChartChart
 
Rubella
ChartChart
  96 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  38  99 
Tetanus (total)**
ChartChart
  10  13  50  188 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Paraguay)
Vaccine year result method % card seen                                                
BCG          84  77  72  75  76  79  92  31 
DTP1          84  78  73  76  76  73 
DTP3          80  74  73  74  76  80  80  17 
DTP4          64  61 
IPV1         
HepB_BD          78 
HepB3          80  74  73  74  76 
Hib3          80  74  73  74  76 
JapEnc         
MCV1          66  72  75  74  76  92  71  19 
MCV2          60  64  64  62  65 
PCV1          84  78  73  99 
PCV3          75  71  81  82 
Pol3          80  74  71  74  75  73  78  13 
Rota1          83  75  71  74  74 
RotaC          79  72  70  71  72 
RCV1          66  73  75  74  77 
TT2plus 1997  93  MCH     29  33  34  55  29 
PAB         
VAD1         
YFV          71  63  80  34  69 
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Paraguay)
BCG
ChartChart
  99  95  90  93  94  85  75  31 
DTP1
ChartChart
  99  98  93  96  96  95  86  40 
DTP3
ChartChart
  93  87  86  87  89  86  67  17 
HepB3
ChartChart
  93  87  86  87  89 
HepB_BD
ChartChart
 
Hib3
ChartChart
  87  87  86  87  89 
IPV1
ChartChart
 
MCV1
ChartChart
  83  89  92  91  93  92  69  19 
MCV2
ChartChart
  77  81  81  79  82 
PAB
ChartChart
  85  85  85  85  85  47  66  26 
PCV3
ChartChart
  92  88  90  82 
Pol3
ChartChart
  89  83  80  83  84  86  64  14 
RCV1
ChartChart
  83  89  92  91  93  92 
RotaC
ChartChart
  92  85  83  85  85 

Number of districts in the country 250  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 18
From 80 to 89% 21
From 50 to 79% 52
Less than 50% 8
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 18 months; 4 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HIB 1st contact; Yes immunocompromized
HPV 10 years; +1, +6 months; Yes
HepA 15 months; Yes
HepB_Adult 1st contact; +1, +6 months; Yes risk groups
HepB_Pediatric births; Yes newborns at risk
IPV 2, 4, 6, 18 months; 4 years; Yes risk groups
Influenza_Adult Yes adults with chronic diseases, pregnant women, health care workers and other risk groups
Influenza_Pediatric 6-35 months; Yes children with chronic diseases
MMR 1, 4 years; Yes
MR 1st contact; Yes not vaccinated
MenACWY Yes risk groups
OPV 2, 4, 6, 18 months; 4 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps >= 60 years Yes and risk groups
Rotavirus 2, 4 months; Yes
Td 1st contact; +1 month; +1, +1, +1 year; Yes CBAW and >Y7 and risk group
Tdap 10 years; Yes
Typhoid 1st contact; international travelers
Varicella 15 months; Yes
YF 12 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  No 
What years does the MYP cover? number 2'014  2'014  2012-2016  2012-2016  2012-2016     
Nº of districts with microplans that include activities to raise immunization coverage number   245  241  240  238  238  234 

System performance

Total Nº districts in country number 250  245  241  240  238  241  234 
Nº districts with DTP3 coverage >=80% number 98  81  78  86  87  86  74 
% of districts with DTP3 coverage >=80% From 0 to 100% 39  33  32  36  37  36  32 
Nº districts with measles (MCV1) coverage >=95% number 11  24  33  27  39  37  27 
% of districts with MCV1 coverage >=95% From 0 to 100% 10  14  11  16  15  12 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100    99  97  94  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Sources

 1  "The 2016 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.